Skip to content

The investigation of treatment for major depression compared monotherapy of mirtazapine, sertraline or duloxetine with combination therapy of mirtazapine and sertraline, or mirtazapine and duloxetine

The investigation of treatment for major depression compared monotherapy of mirtazapine, sertraline or duloxetine with combination therapy of mirtazapine and sertraline, or mirtazapine and duloxetine - The investigation of treatment for major depression compared monotherapy of mirtazapine, sertraline or duloxetine with combination therapy of mirtazapine and sertraline, or mirtazapine and duloxetine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004567
Enrollment
500
Registered
2011-04-01
Start date
2010-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression

Interventions

Drug: mirtazapine Period: 6 months Dose: dose according to drug information Drug: sertraline Period: 6 months Dose: dose according to drug information Drug: duloxetine Period: 6 months Dose: dos

Sponsors

Kenichi Osada
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients that the total poit of teh item (No.1-17) of the Hamilton's deressive scale are more than 18 point.

Exclusion criteria

Exclusion criteria: The patints with a heavy suicide idea The patints wuth severe physical diseases

Design outcomes

Primary

MeasureTime frame
Hamilton's Rating Scale for Depression SF-36 Pittsburgh Sleep Quality Index Clinical Global Impression The UKU side effect rating scale

Secondary

MeasureTime frame
Antidepressants side effect interview sheet (St. Marianna University School of Medicine version)

Countries

Japan

Contacts

Public ContactKenichi Osada

St. Marianna University School of Medicine Neuropsychiatry

k2osada@marianna-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026